Loading…
Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1
Caveolin-1(Cav-1) scaffolding domain (CSD) peptides compete with the plasma membrane Cav-1, inhibit the interaction of the proteins and Cav-1, and re-store the functions of Cav-1 binding proteins. Heme oxygenase-1 (HO-1) binds to Cav-1 and its enzymatic activity was inhibited. In this study, we inve...
Saved in:
Published in: | Oncotarget 2017-06, Vol.8 (25), p.40104-40114 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3 |
---|---|
cites | cdi_FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3 |
container_end_page | 40114 |
container_issue | 25 |
container_start_page | 40104 |
container_title | Oncotarget |
container_volume | 8 |
creator | Weng, Ping Zhang, Xiao-Tong Sheng, Qiong Tian, Wen-Fang Chen, Jun-Liang Yuan, Jia-Jia Zhang, Ji-Ru Pang, Qing-Feng |
description | Caveolin-1(Cav-1) scaffolding domain (CSD) peptides compete with the plasma membrane Cav-1, inhibit the interaction of the proteins and Cav-1, and re-store the functions of Cav-1 binding proteins. Heme oxygenase-1 (HO-1) binds to Cav-1 and its enzymatic activity was inhibited. In this study, we investigated the effect of CSD peptides on interaction between HO-1 and Cav-1, and on the HO-1 activity in vitro and in vivo. Our data showed that CSD peptides decreased the compartmentalization of HO-1 and Cav-1, and increased the HO-1 activity both in LPS-treated alveolar macrophages and in mice. Meanwhile, CSD peptides obviously ameliorated the pathology changes in mice and lowered the following injury indexes: the wet/dry ratio of lung tissues, total cell numbers in bronchoalveolar lavage fluid and lactate dehydrogenase activity in the serum. Mechanistically, it was firstly found that CSD peptides promoted alveolar macrophages polarization to M2 phenotype and inhibited the IκB degeneration. Furthermore, CSD peptides down-regulated the expression of IL-1β, IL-6, TNF-α, MCP-1, and iNOS in alveolar macrophages and in lung tissue. However, the protective role of CSD peptides on LPS-induced acute lung injury in mice could be abolished by zinc protoporphyrin IX (ZnPP, a HO-1 activity inhibitor). In summary, CSD peptides have beneficial anti-inflammatory effects by restoring the HO-1 activity suppressed by Cav-1 on plasma membrane. |
doi_str_mv | 10.18632/oncotarget.16676 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5522314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1887429336</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3</originalsourceid><addsrcrecordid>eNpVkctu1TAQhiNERau2D9AN8pJNSnxLnA0SOuImVWJD19bEHidGiX2wncJ5CN6ZqKccymxmNDP_NyP9VXVDm1uqWs7exmBigTRiuaVt27Uvqgvai75mUvKXz-rz6jrn780WUnSK9a-qc6ZEw3rJLqrfO3jAOPtQU5INOBdn68NIbFzAB7LHffEWM8EwQTBIIBRf--BmWBYoMR0IOoemkOjIhAuS-OswYoCMG7BMKa7jRHwomNK6oTayL_nYgE3105eJmNMLV9WZgznj9VO-rO4_fvi2-1zfff30Zff-rjZMtaU2tpOWgpVoWdt0amgUF51RrcMWlOsHbhvRGxBSMsOp7IbGdah6w4QajAV-Wb07cvfrsKA1GEqCWe-TXyAddASv_58EP-kxPugNyDgVG-DNEyDFHyvmohefDc4zBIxr1lSpTrCe83ZbpcdVk2LOCd3pDG30o5P6n5P60clN8_r5fyfFX9_4Hy04oXo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1887429336</pqid></control><display><type>article</type><title>Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1</title><source>PubMed Central</source><creator>Weng, Ping ; Zhang, Xiao-Tong ; Sheng, Qiong ; Tian, Wen-Fang ; Chen, Jun-Liang ; Yuan, Jia-Jia ; Zhang, Ji-Ru ; Pang, Qing-Feng</creator><creatorcontrib>Weng, Ping ; Zhang, Xiao-Tong ; Sheng, Qiong ; Tian, Wen-Fang ; Chen, Jun-Liang ; Yuan, Jia-Jia ; Zhang, Ji-Ru ; Pang, Qing-Feng</creatorcontrib><description>Caveolin-1(Cav-1) scaffolding domain (CSD) peptides compete with the plasma membrane Cav-1, inhibit the interaction of the proteins and Cav-1, and re-store the functions of Cav-1 binding proteins. Heme oxygenase-1 (HO-1) binds to Cav-1 and its enzymatic activity was inhibited. In this study, we investigated the effect of CSD peptides on interaction between HO-1 and Cav-1, and on the HO-1 activity in vitro and in vivo. Our data showed that CSD peptides decreased the compartmentalization of HO-1 and Cav-1, and increased the HO-1 activity both in LPS-treated alveolar macrophages and in mice. Meanwhile, CSD peptides obviously ameliorated the pathology changes in mice and lowered the following injury indexes: the wet/dry ratio of lung tissues, total cell numbers in bronchoalveolar lavage fluid and lactate dehydrogenase activity in the serum. Mechanistically, it was firstly found that CSD peptides promoted alveolar macrophages polarization to M2 phenotype and inhibited the IκB degeneration. Furthermore, CSD peptides down-regulated the expression of IL-1β, IL-6, TNF-α, MCP-1, and iNOS in alveolar macrophages and in lung tissue. However, the protective role of CSD peptides on LPS-induced acute lung injury in mice could be abolished by zinc protoporphyrin IX (ZnPP, a HO-1 activity inhibitor). In summary, CSD peptides have beneficial anti-inflammatory effects by restoring the HO-1 activity suppressed by Cav-1 on plasma membrane.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.16676</identifier><identifier>PMID: 28402952</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Acute Lung Injury - chemically induced ; Acute Lung Injury - metabolism ; Acute Lung Injury - prevention & control ; Animals ; Caveolin 1 - metabolism ; Caveolin 1 - pharmacology ; Cells, Cultured ; Cytokines - genetics ; Cytokines - metabolism ; Gene Expression - drug effects ; Heme Oxygenase-1 - metabolism ; Inflammation Mediators - metabolism ; Lipopolysaccharides ; Lung - drug effects ; Lung - metabolism ; Lung - pathology ; Macrophage Activation - drug effects ; Macrophages, Alveolar - drug effects ; Macrophages, Alveolar - metabolism ; Male ; Mice, Inbred BALB C ; Peptide Fragments - pharmacology ; Protective Agents - pharmacology ; Protein Binding - drug effects ; Research Paper</subject><ispartof>Oncotarget, 2017-06, Vol.8 (25), p.40104-40114</ispartof><rights>Copyright: © 2017 Weng et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3</citedby><cites>FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522314/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522314/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28402952$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Weng, Ping</creatorcontrib><creatorcontrib>Zhang, Xiao-Tong</creatorcontrib><creatorcontrib>Sheng, Qiong</creatorcontrib><creatorcontrib>Tian, Wen-Fang</creatorcontrib><creatorcontrib>Chen, Jun-Liang</creatorcontrib><creatorcontrib>Yuan, Jia-Jia</creatorcontrib><creatorcontrib>Zhang, Ji-Ru</creatorcontrib><creatorcontrib>Pang, Qing-Feng</creatorcontrib><title>Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Caveolin-1(Cav-1) scaffolding domain (CSD) peptides compete with the plasma membrane Cav-1, inhibit the interaction of the proteins and Cav-1, and re-store the functions of Cav-1 binding proteins. Heme oxygenase-1 (HO-1) binds to Cav-1 and its enzymatic activity was inhibited. In this study, we investigated the effect of CSD peptides on interaction between HO-1 and Cav-1, and on the HO-1 activity in vitro and in vivo. Our data showed that CSD peptides decreased the compartmentalization of HO-1 and Cav-1, and increased the HO-1 activity both in LPS-treated alveolar macrophages and in mice. Meanwhile, CSD peptides obviously ameliorated the pathology changes in mice and lowered the following injury indexes: the wet/dry ratio of lung tissues, total cell numbers in bronchoalveolar lavage fluid and lactate dehydrogenase activity in the serum. Mechanistically, it was firstly found that CSD peptides promoted alveolar macrophages polarization to M2 phenotype and inhibited the IκB degeneration. Furthermore, CSD peptides down-regulated the expression of IL-1β, IL-6, TNF-α, MCP-1, and iNOS in alveolar macrophages and in lung tissue. However, the protective role of CSD peptides on LPS-induced acute lung injury in mice could be abolished by zinc protoporphyrin IX (ZnPP, a HO-1 activity inhibitor). In summary, CSD peptides have beneficial anti-inflammatory effects by restoring the HO-1 activity suppressed by Cav-1 on plasma membrane.</description><subject>Acute Lung Injury - chemically induced</subject><subject>Acute Lung Injury - metabolism</subject><subject>Acute Lung Injury - prevention & control</subject><subject>Animals</subject><subject>Caveolin 1 - metabolism</subject><subject>Caveolin 1 - pharmacology</subject><subject>Cells, Cultured</subject><subject>Cytokines - genetics</subject><subject>Cytokines - metabolism</subject><subject>Gene Expression - drug effects</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Inflammation Mediators - metabolism</subject><subject>Lipopolysaccharides</subject><subject>Lung - drug effects</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophages, Alveolar - drug effects</subject><subject>Macrophages, Alveolar - metabolism</subject><subject>Male</subject><subject>Mice, Inbred BALB C</subject><subject>Peptide Fragments - pharmacology</subject><subject>Protective Agents - pharmacology</subject><subject>Protein Binding - drug effects</subject><subject>Research Paper</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkctu1TAQhiNERau2D9AN8pJNSnxLnA0SOuImVWJD19bEHidGiX2wncJ5CN6ZqKccymxmNDP_NyP9VXVDm1uqWs7exmBigTRiuaVt27Uvqgvai75mUvKXz-rz6jrn780WUnSK9a-qc6ZEw3rJLqrfO3jAOPtQU5INOBdn68NIbFzAB7LHffEWM8EwQTBIIBRf--BmWBYoMR0IOoemkOjIhAuS-OswYoCMG7BMKa7jRHwomNK6oTayL_nYgE3105eJmNMLV9WZgznj9VO-rO4_fvi2-1zfff30Zff-rjZMtaU2tpOWgpVoWdt0amgUF51RrcMWlOsHbhvRGxBSMsOp7IbGdah6w4QajAV-Wb07cvfrsKA1GEqCWe-TXyAddASv_58EP-kxPugNyDgVG-DNEyDFHyvmohefDc4zBIxr1lSpTrCe83ZbpcdVk2LOCd3pDG30o5P6n5P60clN8_r5fyfFX9_4Hy04oXo</recordid><startdate>20170620</startdate><enddate>20170620</enddate><creator>Weng, Ping</creator><creator>Zhang, Xiao-Tong</creator><creator>Sheng, Qiong</creator><creator>Tian, Wen-Fang</creator><creator>Chen, Jun-Liang</creator><creator>Yuan, Jia-Jia</creator><creator>Zhang, Ji-Ru</creator><creator>Pang, Qing-Feng</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170620</creationdate><title>Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1</title><author>Weng, Ping ; Zhang, Xiao-Tong ; Sheng, Qiong ; Tian, Wen-Fang ; Chen, Jun-Liang ; Yuan, Jia-Jia ; Zhang, Ji-Ru ; Pang, Qing-Feng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute Lung Injury - chemically induced</topic><topic>Acute Lung Injury - metabolism</topic><topic>Acute Lung Injury - prevention & control</topic><topic>Animals</topic><topic>Caveolin 1 - metabolism</topic><topic>Caveolin 1 - pharmacology</topic><topic>Cells, Cultured</topic><topic>Cytokines - genetics</topic><topic>Cytokines - metabolism</topic><topic>Gene Expression - drug effects</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Inflammation Mediators - metabolism</topic><topic>Lipopolysaccharides</topic><topic>Lung - drug effects</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophages, Alveolar - drug effects</topic><topic>Macrophages, Alveolar - metabolism</topic><topic>Male</topic><topic>Mice, Inbred BALB C</topic><topic>Peptide Fragments - pharmacology</topic><topic>Protective Agents - pharmacology</topic><topic>Protein Binding - drug effects</topic><topic>Research Paper</topic><toplevel>online_resources</toplevel><creatorcontrib>Weng, Ping</creatorcontrib><creatorcontrib>Zhang, Xiao-Tong</creatorcontrib><creatorcontrib>Sheng, Qiong</creatorcontrib><creatorcontrib>Tian, Wen-Fang</creatorcontrib><creatorcontrib>Chen, Jun-Liang</creatorcontrib><creatorcontrib>Yuan, Jia-Jia</creatorcontrib><creatorcontrib>Zhang, Ji-Ru</creatorcontrib><creatorcontrib>Pang, Qing-Feng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weng, Ping</au><au>Zhang, Xiao-Tong</au><au>Sheng, Qiong</au><au>Tian, Wen-Fang</au><au>Chen, Jun-Liang</au><au>Yuan, Jia-Jia</au><au>Zhang, Ji-Ru</au><au>Pang, Qing-Feng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-06-20</date><risdate>2017</risdate><volume>8</volume><issue>25</issue><spage>40104</spage><epage>40114</epage><pages>40104-40114</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Caveolin-1(Cav-1) scaffolding domain (CSD) peptides compete with the plasma membrane Cav-1, inhibit the interaction of the proteins and Cav-1, and re-store the functions of Cav-1 binding proteins. Heme oxygenase-1 (HO-1) binds to Cav-1 and its enzymatic activity was inhibited. In this study, we investigated the effect of CSD peptides on interaction between HO-1 and Cav-1, and on the HO-1 activity in vitro and in vivo. Our data showed that CSD peptides decreased the compartmentalization of HO-1 and Cav-1, and increased the HO-1 activity both in LPS-treated alveolar macrophages and in mice. Meanwhile, CSD peptides obviously ameliorated the pathology changes in mice and lowered the following injury indexes: the wet/dry ratio of lung tissues, total cell numbers in bronchoalveolar lavage fluid and lactate dehydrogenase activity in the serum. Mechanistically, it was firstly found that CSD peptides promoted alveolar macrophages polarization to M2 phenotype and inhibited the IκB degeneration. Furthermore, CSD peptides down-regulated the expression of IL-1β, IL-6, TNF-α, MCP-1, and iNOS in alveolar macrophages and in lung tissue. However, the protective role of CSD peptides on LPS-induced acute lung injury in mice could be abolished by zinc protoporphyrin IX (ZnPP, a HO-1 activity inhibitor). In summary, CSD peptides have beneficial anti-inflammatory effects by restoring the HO-1 activity suppressed by Cav-1 on plasma membrane.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>28402952</pmid><doi>10.18632/oncotarget.16676</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2017-06, Vol.8 (25), p.40104-40114 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5522314 |
source | PubMed Central |
subjects | Acute Lung Injury - chemically induced Acute Lung Injury - metabolism Acute Lung Injury - prevention & control Animals Caveolin 1 - metabolism Caveolin 1 - pharmacology Cells, Cultured Cytokines - genetics Cytokines - metabolism Gene Expression - drug effects Heme Oxygenase-1 - metabolism Inflammation Mediators - metabolism Lipopolysaccharides Lung - drug effects Lung - metabolism Lung - pathology Macrophage Activation - drug effects Macrophages, Alveolar - drug effects Macrophages, Alveolar - metabolism Male Mice, Inbred BALB C Peptide Fragments - pharmacology Protective Agents - pharmacology Protein Binding - drug effects Research Paper |
title | Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T20%3A15%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Caveolin-1%20scaffolding%20domain%20peptides%20enhance%20anti-inflammatory%20effect%20of%20heme%20oxygenase-1%20through%20interrupting%20its%20interact%20with%20caveolin-1&rft.jtitle=Oncotarget&rft.au=Weng,%20Ping&rft.date=2017-06-20&rft.volume=8&rft.issue=25&rft.spage=40104&rft.epage=40114&rft.pages=40104-40114&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.16676&rft_dat=%3Cproquest_pubme%3E1887429336%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c286t-cd75d1ad5ed26078b08347c86fe6a8f9b3d049ca4552c3157b0f7e89c248bcda3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1887429336&rft_id=info:pmid/28402952&rfr_iscdi=true |